"Seventeen years ago, when I walked into my first IAS Conference in Cape Town, I wondered where I belonged. Today, I begin this new chapter deeply honoured to serve this remarkable organization."
- Incoming @iasociety President @KNgure. Learn more about his vision for the International AIDS Society and the global #HIV response: https://t.co/pV6evlG74j
#AIDS2026 #RethinkRebuildRise
The @AIDS_conference may be over, but the work of turning its evidence, ideas and commitments into action continues.
▶️ Watch Andriy Klepikov’s reflections from Rio.
#AIDS2026@iasociety@andriyklepikov
The greatest threat to global health is not a lack of science or solutions. It is inequality.
To end AIDS and to prevent future pandemics, we must remove the barriers that keep lifesaving services & medicines out of reach for millions.
#AIDS2026 #RethinkRebuildRise
https://t.co/BzD4c4ISDq
🌍 The momentum from #AIDS2026 continues as we take the partnerships, ideas and lessons from #Rio back to countries and communities around the world.
📽️ Hear @AchrekarAngeli, @UNAIDS Deputy Executive Director and Global Practice Lead, reflect on how we can turn what we started to build together at AIDS 2026 into lasting impact.
#RethinkRebuildRise @GLN_Community
@WHO's @ANJSeale named 3 forces shaping the HIV response in Rio: long-acting antiretrovirals, integrated services, and recovering from funding disruptions. Can the field manage all 3 at once? #AIDS2026 🎙️ Listen to our HIV ep https://t.co/tgwTok3gd4
⚡️@iasociety@AIDS_conference
New monthly HIV prevention pill, in late-stage trials, could provide a giant step forward in stopping new HIV infections.
If proved effective, UNAIDS highlights that speed, affordability and equitable access will be critical.
Read press release: https://t.co/jiRXiGJpMZ
Powerful anti-HIV drugs took another step forward at the 26th International AIDS Conference.
Among the most exciting findings were studies showing one pill a week could be enough to keep HIV under control in people living with the virus—a significant improvement over the current once-a-day regimen.
But vaccine development, which has struggled even as treatments advance, faced new questions as a study highlighted the limits of unusually powerful antibodies that the leading vaccine candidates aim to trigger.
Learn more: https://t.co/5Favh1w1UL
We spoke with amfAR scientists and staff on the ground at #AIDS2026 about what most inspired them at the conference. Here’s what they had to say, and you can find more updates here: https://t.co/aTTbPVXgHo
"Would people choose injectable PrEP? Would they keep coming back? Would protection remain high? The answer to all three is yes." — @HIVpxresearch's Mitchell Warren on new HIV prevention data from #AIDS2026. #IAS2026
https://t.co/Q7rFIyZHDG
A moment to pause amidst a busy week at the @AIDS_conference 🇧🇷
Proud of our incredible team and grateful for the many partners, advocates and friends we had the chance to connect with throughout #AIDS2026.
#AIDS2026 may be over, but the conversation isn't.
There's still time to complete the #VibrantYoungVoices advocacy survey and help shape community-led action on youth HIV advocacy. Complete the survey 👉🏼 https://t.co/Zwp76rAt6G
Your voice still matters.
New findings from the Mobile Men Study, presented at #AIDS2026, show that long-acting injectable #PrEP helped men who travel for work stay on HIV prevention for longer than oral PrEP.
What did researchers discover, and why does offering people a choice of HIV prevention options matter?
Read the full story here: https://t.co/ytq9fo33UN
As the lights dimmed on #AIDS2026, leaders called for countries to take greater ownership of their HIV responses, protect civic space, invest in young leaders, and ensure that scientific advances reach the people who need them most.
Our final dispatch from #AIDS2026 reflects on the conversations, commitments, and unanswered questions that will shape the next chapter of the global HIV response
Read full dispatch here: https://t.co/HH4h3VDPpE
Missed #AIDS2026? The International AIDS Society has put together a strong summary of key takeaways from AIDS 2026, covering everything from the funding landscape to the science shared in Rio de Janeiro.
Read the article here: https://t.co/36qKRtke4R @iasociety
The IAS stands in firm support of Dr Anthony #Fauci and his five decades of evidence-based public health leadership. Following science through politically fraught pandemics and speaking truth to power is vital to global health.
Read our full letter: https://t.co/idZs92aKuT
🇿🇦 South Africa returned from the International Aids Conference in Rio with big HIV announcements:
💉 A new PrEP dashboard
💊 A licence to make a monthly HIV prevention pill
🏭 Progress towards making lenacapavir (LEN) locally
Here's what they mean. https://t.co/qIAOe9MES3
#Aids2026 #HIV #PrEP
AI is opening new possibilities across the HIV response, but as its use expands, so do questions about trust, bias, privacy, governance and who gets left behind.
At #AIDS2026, a conversation on the future of HIV explored these questions alongside another growing reality: how to help people ageing with HIV live well, not just longer.
Read full dispatch here: https://t.co/KTiwvv82Nw